Skip to main content

How safe are your prescription drugs?

By Aaron Carroll
updated 8:37 AM EST, Tue February 25, 2014
Customs in Brussels, Belgium, seized more than 2 million counterfeit pills made in India and bound for Africa in 2008.
Customs in Brussels, Belgium, seized more than 2 million counterfeit pills made in India and bound for Africa in 2008.
STORY HIGHLIGHTS
  • Aaron Carroll: Americans worry about safety of buying cheaper drugs in Canada
  • Carroll: We import 40% of our drugs from India; contamination and fake pills are a problem
  • He says India allowed inspections; China, which also makes drugs, resists them
  • Carroll: We need to support the government in its efforts to protect us overseas

Editor's note: Aaron E. Carroll is a professor of pediatrics at the Indiana University School of Medicine and the director of its Center for Health Policy and Professionalism Research. He blogs about health policy at The Incidental Economist and tweets at @aaronecarroll.

(CNN) -- Every once in a while, people get all crazy about the idea that some people might "import" drugs from Canada. Many pharmaceuticals are much cheaper in that country and many Americans, especially those who live on the border, are sometimes tempted to buy their drugs there.

Inevitably, when this topic comes up for debate, someone questions the safety of those drugs. This concern is somewhat overblown. Canada isn't a banana republic, and it does a rather good job of ensuring the safety of its citizens without our help.

Aaron Carroll
Aaron Carroll

Moreover, it's a concern that ignores that the vast, vast majority of drugs we buy here are not manufactured here. We import most of what we consume.

For some reason, we don't seem to be as concerned about the safety of our drugs here are home. It turns out, though, that we might need to rethink that, according to a recent story in The New York Times.

For some time, many people, including me, have been advocating for greater use of generic and over-the-counter drugs over bioequivalent name brand drugs because they would result in significantly decreased health care spending. Those arguments have resonated with the American people, and generic drug use has increased dramatically. In response, countries have massively increased their capacity to produce such drugs.

For instance, about 40% of all over-the-counter and generic drugs used in the United States are produced in India. In response to this and other factors, the Food and Drug Administration Safety and Innovation Act was passed in July of 2012. Part of the law involved changes to generic drug user fees. Companies looking for approval now need to pay some extra money to allow for better inspection of production facilities.

And in India, those inspections are bearing fruit.

This is leading many pharmaceutical companies to question whether India is a safe ... place to manufacture their drugs. India's drug industry is in a panic.
Aaron Carroll

Last year, inspectors from the FDA looked at 160 drug plants there. What they found was often quite concerning. Drugs were sometimes adulterated or contaminated. Facilities were often filthy or infested with bugs. They also caught some executives lying to them, leading to felony charges.

As you can imagine, this is leading many pharmaceutical companies to question whether India is a safe and reasonable place to manufacture their drugs. India's drug industry is in a panic.

They should be. The World Health Organization has, for years, monitored the use of falsified or counterfeit medicines, and some of the problems have been in the United States. The New York Times documents many instances in many countries where improperly made or counterfeit drugs led to serious consequences, including deaths.

Many people have legitimate concerns about how much regulation goes into the approval of drugs in the United States. Some believe the FDA is too cautious and makes it too difficult for people to get the medicines they want or need. But examples like this are a cautionary tale about how some regulation is necessary.

Without proper oversight, people in the United States, not some Third World nation, are at risk for buying counterfeit drugs in their pharmacies. They are at risk not only for not getting the benefit they expect but also a negative consequence they didn't see coming.

In many ways, you get what you pay for. Companies have been using India for production largely because they have been able to do it so cheaply. But it's becoming apparent that one of the reasons for those low costs may be because they were doing a much less-than-perfect job. Fixing the problem will likely mean that they will lose their competitive advantage.

If pharmaceutical companies move out of India, they will likely decide to go to other countries that can also offer cheap services. One of those is likely China. But China, unlike India, has blocked U.S. efforts to send FDA inspectors. We're in a similar situation to what we had in India before the increased oversight.

This is far from over. We need to be vigilant. We also need to support the government in its efforts to protect us overseas. Fixing this problem, both now and in the future, will require resources and a firm stance. It may also require us to pay more for our drugs than we have in the past.

That won't be popular, but sometimes good things cost money.

Follow us on Twitter @CNNOpinion

Join us on Facebook/CNNOpinion

The opinions expressed in this commentary are solely those of Aaron Carroll.

ADVERTISEMENT
Part of complete coverage on
updated 1:33 AM EST, Thu December 25, 2014
Danny Cevallos says the legislature didn't have to get involved in regulating how people greet each other
updated 6:12 PM EST, Tue December 23, 2014
Marc Harrold suggests a way to move forward after the deaths of NYPD officers Wenjian Liu and Rafael Ramos.
updated 8:36 AM EST, Wed December 24, 2014
Simon Moya-Smith says Mah-hi-vist Goodblanket, who was killed by law enforcement officers, deserves justice.
updated 2:14 PM EST, Wed December 24, 2014
Val Lauder says that for 1,700 years, people have been debating when, and how, to celebrate Christmas
updated 3:27 PM EST, Tue December 23, 2014
Raphael Sperry says architects should change their ethics code to ban involvement in designing torture chambers
updated 10:35 PM EST, Tue December 23, 2014
Paul Callan says Sony is right to call for blocking the tweeting of private emails stolen by hackers
updated 7:57 AM EST, Tue December 23, 2014
As Christmas arrives, eyes turn naturally toward Bethlehem. But have we got our history of Christmas right? Jay Parini explores.
updated 11:29 PM EST, Mon December 22, 2014
The late Joe Cocker somehow found himself among the rock 'n' roll aristocracy who showed up in Woodstock to help administer a collective blessing upon a generation.
updated 4:15 PM EST, Tue December 23, 2014
History may not judge Obama kindly on Syria or even Iraq. But for a lame duck president, he seems to have quacking left to do, says Aaron Miller.
updated 1:11 PM EST, Tue December 23, 2014
Terrorism and WMD -- it's easy to understand why these consistently make the headlines. But small arms can be devastating too, says Rachel Stohl.
updated 1:08 PM EST, Mon December 22, 2014
Ever since "Bridge-gate" threatened to derail Chris Christie's chances for 2016, Jeb Bush has been hinting he might run. Julian Zelizer looks at why he could win.
updated 1:53 PM EST, Sat December 20, 2014
New York's decision to ban hydraulic fracturing was more about politics than good environmental policy, argues Jeremy Carl.
updated 3:19 PM EST, Sat December 20, 2014
On perhaps this year's most compelling drama, the credits have yet to roll. But we still need to learn some cyber lessons to protect America, suggest John McCain.
updated 5:39 PM EST, Mon December 22, 2014
Conservatives know easing the trade embargo with Cuba is good for America. They should just admit it, says Fareed Zakaria.
updated 8:12 PM EST, Fri December 19, 2014
We're a world away from Pakistan in geography, but not in sentiment, writes Donna Brazile.
updated 12:09 PM EST, Fri December 19, 2014
How about a world where we have murderers but no murders? The police still chase down criminals who commit murder, we have trials and justice is handed out...but no one dies.
updated 6:45 PM EST, Thu December 18, 2014
The U.S. must respond to North Korea's alleged hacking of Sony, says Christian Whiton. Failing to do so will only embolden it.
updated 4:34 PM EST, Fri December 19, 2014
President Obama has been flexing his executive muscles lately despite Democrat's losses, writes Gloria Borger
updated 2:51 PM EST, Thu December 18, 2014
Jeff Yang says the film industry's surrender will have lasting implications.
updated 4:13 PM EST, Thu December 18, 2014
Newt Gingrich: No one should underestimate the historic importance of the collapse of American defenses in the Sony Pictures attack.
updated 7:55 AM EST, Wed December 10, 2014
Dean Obeidallah asks how the genuine Stephen Colbert will do, compared to "Stephen Colbert"
updated 12:34 PM EST, Thu December 18, 2014
Some GOP politicians want drug tests for welfare recipients; Eric Liu says bailed-out execs should get equal treatment
updated 8:42 AM EST, Thu December 18, 2014
Louis Perez: Obama introduced a long-absent element of lucidity into U.S. policy on Cuba.
updated 12:40 PM EST, Tue December 16, 2014
The slaughter of more than 130 children by the Pakistani Taliban may prove as pivotal to Pakistan's security policy as the 9/11 attacks were for the U.S., says Peter Bergen.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT